Mendor has undergone an impressive journey and growth based on a combination of factors:
our team of dedicated professionals, unbeatable product portfolio and highly passionate and motivated partners.
We strive and are committed to continue to develop and market products and solutions which drives a significant improved care and management of diabetes, both for the individual as well as for the clinic – at significant reduced cost and increased quality of life.
Mendor is supported by a large number of shareholders, both individuals as well as large and international investment firms. In total Mendor has more than 30 different shareholders.
If you are interested in learning more about our strategy and partner opportunities, please contact: